Aim <p>To determine risk of subsequent reaction to field bee sting in children who received bee venom immunotherapy.</p> Method <p>We followed up patients that underwent bee venom immunotherapy. This is a retrospective review of patients who underwent bee venom immunotherapy at Princess Margaret Hospital (PMH) and Perth Children’s Hospital (PCH) between January 2009 -December 2023. Questionnaire was sent to patients to ascertain if they experienced any field bee stings following bee venom immunotherapy (HBVIT). A total of 357 patients were referred for HBVIT between January 2009-December 2023 at Princess Margaret Hospital and Perth Children’s Hospital, Perth, Western Australia. Of the 357 patients contacted, 187 (52.3%) patients completed the questionnaire and 153 (42.8%) met criteria for inclusion in the study. 34 patients had not completed HBVIT in December 2023 and were not included in the study. 2 patients (1.3%) patients experienced Anaphylaxis following HBVIT. We found a high protection rate of HBVIT.</p> Results <p>2 patients (1.3%) experienced anaphylaxis following HBVIT. </p> Conclusion <p>Our findings indicate a high protection rate from HBVIT.</p>